PRV-1, erythroid colonies and platelet Mpl are unrelated to thrombosis in essential thrombocythaemia

British Journal of Haematology

Volumn 127, Issue 2, 2004, Pages 214-219

  Vannucchi, Alessandro M ^a   Grossi, Alberto ^a   Pancrazzi, Alessandro ^a   Antonioli, Elisabetta ^a   Guglielmelli, Paola ^a   Balestri, Francesca ^a   Biscardi, Monica ^a   Bulgarelli, Simona ^b   Longo, Giovanni ^a   Graziano, Claudio ^a   Gugliotta, Luigi ^b   Bosi, Alberto ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Arcispedale Santa Maria Nuova   (Italy)

Author keywords

Endogenous erythoid colonies; Mpl; PRV 1; Thrombocythaemia; Thrombosis

Indexed keywords

CELL PROTEIN; PROTEIN MPL; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; COLONY FORMATION; EPIGENETICS; ERYTHROID CELL; FEMALE; GENE; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MYELOPOIESIS; PHENOTYPE; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; PRV 1 GENE; THROMBOCYTHEMIA; THROMBOSIS; X CHROMOSOME INACTIVATION;

ADULT; BLOOD PLATELETS; CLONE CELLS; DOSAGE COMPENSATION, GENETIC; ERYTHROID PROGENITOR CELLS; FEMALE; GENE EXPRESSION; HUMANS; ISOANTIGENS; LOGISTIC MODELS; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MYELOPOIESIS; PREDICTIVE VALUE OF TESTS; RECEPTORS, CELL SURFACE; THROMBOCYTHEMIA, HEMORRHAGIC; THROMBOPOIETIN; THROMBOSIS;

EID: 5644298757     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2004.05175.x     Document Type: Article

References (34)

1. Barbui, T., Barosi, G., Grossi, A., Gugliotta, L., Liberato, L.N., Marchetti, M., Mazzucconi, M.G., Rodeghiero, F. & Tura, S. (2004) Practice guidelines for the therapy of essential thrombocythemia. A statement from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation. Haematologica, 89, 215-232.
2. Champion, K.M., Gilbert, J.G., Asimakopoulos, F.A., Hinshelwood, S. & Green, A.R. (1997) Clonal haemopoiesis in normal elderly women: implications for the myeloproliferative disorders and myelodysplastic syndromes. British Journal of Haematology, 97, 920-926.
3. Chiusolo, P., La Barbera, E.O., Laurenti, L., Piccirillo, N., Sora, F., Giordano, G., Urbano, R., Mazzucconi, M.G., De Stefano, V., Leone, G. & Sica, S. (2001) Clonal hemopoiesis and risk of thrombosis in young female patients with essential thrombocythemia. Experimental Hematology, 29, 670-676.
4. Cortelazzo, S., Viero, P., Finazzi, G., D'Emilio, A., Rodeghiero, F. & Barbui, T. (1990) Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia. Journal of Clinical Oncology, 8, 556-562.
5. Gregory, C.J. & Eaves, A.C. (1977) Human marrow cells capable of erythropoietic differentiation in vitro: definition of three erythroid colony responses. Blood, 49, 855-864.
6. Griesshammer, M., Heimpel, H. & Pearson, T.C. (1996) Essential thrombocythemia and pregnancy. Leukemia Lymphoma, 22(Suppl. 1), 57-63.
7. Griesshammer, M., Klippel, S., Strunck, E., Temerinac, S., Mohr, U., Heimpel, H. & Pahl, H.L. (2004) PRV-1 mRNA expression discriminates two types of essential thrombocythemia. Annals of Hematology, 83, 364-370.
8. Harrison, C.N., Gale, R.E., Machin, S.J. & Linch, D.C. (1999a) A large proportion of patients with a diagnosis of essential thrombocythemia do not have a clonal disorder and may be at lower risk of thrombotic complications. Blood, 93, 417-424.
9. Harrison, C.N., Gale, R.E., Pezella, F., Mire-Sluis, A., MacHin, S.J. & Linch, D.C. (1999b) Platelet c-mpl expression is dysregulated in patients with essential thrombocythaemia but this is not of diagnostic value. British Journal of Haematology, 107, 139-147.
10. Horikawa, Y., Matsumura, I., Hashimoto, K., Shiraga, M., Kosugi, S., Tadokoro, S., Kato, T., Miyazaki, H., Tomiyama, Y., Kurata, Y., Matsuzawa, Y. & Kanakura, Y. (1997) Markedly reduced expression of platelet c-mpl receptor in essential thrombocythemia. Blood, 90, 4031-4038.
11. Imbert, M., Pierre, R., Thiele, J., Vardiman, J.W., Brunning, R.D. & Flandrin, G. (2001) Essential thrombocythaemia. In: WHO Classification of Tumors: Tumors of Hematopoietic and Lymphois Tissues (ed. by E.S. Jaffe, N.L. Harris, H. Stein & J.W. Vardimar), pp. 39-41. LARC Press, Lyon.
12. Johansson, P., Andreasson, B., Safai-Kutti, S., Wennstrom, L., Palmqvist, L., Ricksten, A., Lindstedt, G. & Kutti, J. (2003a) The presence of a significant association between elevated PRV-1 mRNA expression and low plasma erythropoietin concentration in essential thrombocythaemia. European Journal of Haematology, 70, 358-362.
13. Johansson, P., Ricksten, A., Wennstrom, L., Palmqvist, L., Kutti, J. & Andreasson, B. (2003b) Increased risk for vascular complications in PRV-1 positive patients with essential thrombocythaemia. British Journal of Haematology, 123, 513-516.
14. el-Kassar, N., Hetet, G., Briere, J. & Grandchamp, B. (1997) Clonality analysis of hematopoiesis in essential thrombocythemia: advantages of studying T lymphocytes and platelets. Blood, 89, 128-134.
15. Kessler, C.M. (2004) Propensity for hemorrhage and thrombosis in chronic myeloproliferative disorders. Seminars in Hematology, 41, 10-14.
16. Klippel, S., Strunck, E., Temerinac, S., Bench, A.J., Meinhardt, G., Mohr, U., Leichtle, R., Green, A.R., Griesshammer, M., Heimpel, H. & Pahl, H.L. (2003) Quantification of PRV-1 mRNA distinguishes polycythemia vera from secondary erythrocytosis. Blood, 102, 3569-3574.
17. Kralovics, R., Buser, A.S., Teo, S.S., Coers, J., Tichelli, A., van der Maas, A.P. & Skoda, R.C. (2003) Comparison of molecular markers in a cohort of patients with chronic myeloproliferative disorders. Blood, 102, 1869-1871.
18. Landolfi, R., Rocca, B. & Patrono, C. (1995) Bleeding and thrombosis in myeloproliferative disorders: mechanisms and treatment. Critical Reviews in Oncology Hematology, 20, 203-222.
19. Landolfi, R., Marchioli, R., Kutti, J., Gisslinger, H., Tognoni, G., Patrono, C. & Barbui, T. (2004) Efficacy and safety of low-dose aspirin in polycythemia vera. New England Journal of Medicine, 350, 114-124.
20. Li, J., Xia, Y. & Kuter, D.J. (2000) The platelet thrombopoietin receptor number and function are markedly decreased in patients with essential thrombocythaemia. British Journal of Haematology, 111, 943-953.
21. Liu, E., Jelinek, J., Pastore, Y.D., Guan, Y., Prchal, J.F. & Prchal, J.T. (2003) Discrimination of polycythemias and thrombocytoses by novel, simple, accurate clonality assays and comparison with PRV-1 expression and BFU-E response to erythropoietin. Blood, 101, 3294-3301.
22. Mesa, R.A., Hanson, C.A., Li, C.Y., Yoon, S.Y., Rajkumar, S.V., Schroeder, G. & Tefferi, A. (2002) Diagnostic and prognostic value of bone marrow angiogenesis and megakaryocyte c-Mpl expression in essential thrombocythemia. Blood, 99, 4131-4137.
23. Mitterbauer, G., Winkler, K., Gisslinger, H., Geissler, K., Lechner, K. & Mannhalter, C. (1999) Clonality analysis using X-chromosome inactivation at the human androgen receptor gene (Humara). Evaluation of large cohorts of patients with chronic myeloproliferative diseases, secondary neutrophilia, and reactive thrombocytosis. American Journal of Clinical Pathology, 112, 93-100.
24. Moliterno, A.R., Hankins, W.D. & Spivak, J.L. (1998) Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera. New England Journal of Medicine, 338, 572-580.
25. Murphy, S. (1999) Diagnostic criteria and prognosis in polycythemia vera and essential thrombocythemia. Seminars in Hematology, 36, 9-13.
26. Prchal, J.F. & Axelrad, A.A. (1974) Letter: Bone-marrow responses in polycythemia vera. New England Journal of Medicine, 290, 1382.
27. Shih, L.Y., Lin, T.L., Dunn, P., Wu, J.H., Tseng, C.P., Lai, C.L., Wang, P.N. & Kuo, M.C. (2001) Clonality analysis using X-chromosome inactivation patterns by HUMARA-PCR assay in female controls and patients with idiopathic thrombocytosis in Taiwan. Experimental Hematology, 29, 202-208.
28. Shih, L.Y., Lin, T.L., Lai, C.L., Dunn, P., Wu, J.H., Wang, P.N., Kuo, M.C. & Lee, L.C. (2002) Predictive values of X-chromosome inactivation patterns and clinicohematologic parameters for vascular complications in female patients with essential thrombocythemia. Blood, 100, 1596-1601.
29. Spivak, J.L., Barosi, G., Tognoni, G., Barbui, T., Finazzi, G., Marchioli, R. & Marchetti, M. (2003) Chronic Myeloproliferative Disorders. Hematology (American Society of Hematology Educational Program), American Society of Hematology, Washington DC, 200-224.
30. Tefferi, A., Fonseca, R., Pereira, D.L. & Hoagland, H.C. (2001) A long-term retrospective study of young women with essential thrombocythemia. Mayo Clinic Proceedings, 76, 22-28.
31. Tefferi, A., Lasho, T.L., Wolanskyj, A.P. & Mesa, R.A. (2004) Neutrophil PRV-1 expression across the chronic myeloproliferative disorders and in secondary or spurious polycythemia. Blood, 103, 3547-3548.
32. Teofili, L., Martini, M., Luongo, M., Di Mario, A., Leone, G., De Stefano, V. & Larocca, L.M. (2002a) Overexpression of the polycythemia rubra vera-1 gene in essential thrombocythemia. Journal of Clinical Oncology, 20, 4249-4254.
33. Teofili, L., Pierconti, F., Di Febo, A., Maggiano, N., Vianelli, N., Ascani, S., Rossi, E., Pileri, S., Leone, G., Larocca, L.M. & De Stefano, V. (2002b) The expression pattern of c-mpl in megakaryocytes correlates with thrombotic risk in essential thrombocythemia. Blood, 100, 714-717.
34. Thiele, J., Kvasnicka, H.M., Zankovich, R. & Diehl, V. (2001) Clinical and morphological criteria for the diagnosis of prefibrotic idiopathic (primary) myelofibrosis. Annals of Hematology, 80, 160-165.